SS Innovations International (SSII) has seen its stock decline 31.8% over three months amid widening losses, mounting operating expenses, and cash burn concerns. While the company benefits from growing adoption of its robotic surgery systems and expanding global presence, persistent profitability challenges, liquidity constraints, and heavy geographic concentration in India (93% of revenues) remain significant headwinds. The company trades at a premium valuation of 8.64X EV/sales compared to the industry average of 2.78X.
EFOR
Everforth, Inc. · NYSE
News
1 latestNo direct coverage yet · Showing articles that mention EFOR
Headlines link to the publisher. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Posts 24h
0
Replies 24h
0
Watchers
0
Board · $EFOR · 0 threads
Sign in to post on $EFOR
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.